References
- Tesfaye S, Boulton AJ, Dyck PJ, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabet Care. 2010;33:2285–2293.
- Papanas N, Ziegler D. Risk factors and comorbidities in diabetic neuropathy: an update 2015. Rev Diabet Stud. 2015;12:48–62.
- Papanas N, Vinik AI, Ziegler D. Neuropathy in prediabetes: does the clock start ticking early? Nat Rev Endocrinol. 2011;7:682–690.
- Herman WH, Kennedy L. Underdiagnosis of peripheral neuropathy in type 2 diabetes. Diabet Care. 2005;28:1480–1481.
- Papanas N, Ziegler D. New vistas in the diagnosis of diabetic polyneuropathy. Endocrine. 2014;47:690–698.
- Ziegler D, Papanas N, Zhivov A, et al. Early detection of nerve fiber loss by corneal confocal microscopy and skin biopsy in recently diagnosed type 2 diabetes. Diabetes. 2014;63:2454–2463.
- Lee JA, Halpern EM, Lovblom LE, et al. Reliability and validity of a point-of-care sural nerve conduction device for identification of diabetic neuropathy. Plos One. 2014;9:e86515.
- Kong X, Lesser EA, Megerian JT, et al. Repeatability of nerve conduction measurements using automation. J Clin Monit Comput. 2006;20:405–410.
- NC-stat®DPNCheck™.User manual. [cited 2017 Jan 18]. Available from: http://www.dpncheck.com/resources/Resources/nc-stat_dpncheck_user_manual_pn2203282_rev_g.pdf.
- NC-stat®DPNCheck™ Reimbursement FAQs. [cited 2017 Jan 18]. Available from: http://www.dpncheck.com/resources/Resources/nc-stat_dpncheck_reimbursement_faq_final_pn2203566_rev_a.pdf.
- Davis-King KE, Sweeney MH, Wille KK, et al. Reference values for amplitudes and conduction velocities obtained from a cohort of middle-aged and retired workers. Scand J Work Environ Health. 1992;18(Suppl 2):24–26.
- Perkins BA, Grewal J, Ng E, et al. Validation of a novel point-of-care nerve conduction device for the detection of diabetic sensorimotor polyneuropathy. Diabet Care. 2006;29:2023–2027.
- Perkins BA, Orszag A, Grewal J, et al. Multi-site testing with a point-of-care nerve conduction device can be used in an algorithm to diagnose diabetic sensorimotor polyneuropathy. Diabet Care. 2008;31:522–524.
- Pambianco G, Costacou T, Strotmeyer E, et al. The assessment of clinical distal symmetric polyneuropathy in type 1 diabetes: a comparison of methodologies from the pittsburgh epidemiology of diabetes complications cohort. Diabetes Res Clin Pract. 2011;92:280–287.
- Chatzikosma G, Pafili K, Demetriou M, et al. Evaluation of sural nerve automated nerve conduction study in the diagnosis of peripheral neuropathy in patients with type 2 diabetes mellitus. Arch Med Sci. 2016;12:390–393.
- Sharma S, Vas PR, Rayman G. Assessment of diabetic neuropathy using a point-of-care nerve conduction device shows significant associations with the LDIFLARE method and clinical neuropathy scoring. J Diabetes Sci Technol. 2015;9:123–131.
- Sural Nerve Conduction FAQs. [cited 2016 Nov 09]. Available from: http://www.newlinemedical.com/assets/images/gui/NC-stat%20DPNCheck%20Sural%20Nerve%20Conduction%20FAQ%20Rev%20B%20FINAL.pdf.
- The effect of cold on nerve conduction of human slow and fast nerve fibers. [cited 2017 Feb 24]. Available from: http://www.neurology.org/content/23/11/1182.extract.
- Diabetic foot problems: preDiabetic foot problems: prevention and management. [cited 2017 Jan 18]. Available from: http://dermatonics.co.uk/files/1914/4412/5463/NG19_Guidance_20150826.pdf.
- Poulose S, Cheriyan E, Poulose A, et al. Usefulness of the NC-stat DPNCheck nerve conduction test in a community pharmacy as an educational tool for patients with diabetes. Can Pharm J (Ott). 2015;148:17–20.